En español
NIDA

HIV/AIDS

NIDA, ANRS Select Drug Abuse and HIV Research Fellow

Rubén Muñoz, Ph.D., a researcher and teacher at the Latino American Faculty of Social Science (FLACSO) of Ecuador, has been awarded a NIDA-ANRS Drug Abuse and HIV Research Fellowship. NIDA and the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) created the 12-month postdoctoral research fellowship to advance scientific understanding of the linkages between drug abuse and HIV while fostering multinational research. Dr.

International Teams Including Former Fellows Publish Results From Regional HIV Collaborative Research Grants

Former NIDA International fellows and their international partners have published findings from research funded through RFA-DA-10-008, International Research Collaborations on HIV/AIDS and Drug Use. The funding opportunity was issued to stimulate collaborative research among foreign investigators from the same geographic regions to address regional issues on the intersection of HIV/AIDS and drug use in international settings. The articles include:

NIDA, ANRS Create Postdoctoral Drug Abuse and HIV Research Fellowship

NIDA and the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) have created a postdoctoral research fellowship to advance scientific understanding of the linkages between drug abuse and HIV while fostering multinational research. The new fellowship is the fifth postdoctoral fellowship program established under the NIDA International Visiting Scientists and Technical Exchange (INVEST) Program.

RFA Issued for FY14 HIV/AIDS Avant Garde Research Program

NIDA has committed $2 million in fiscal year (FY) 2014 to fund two to three awards for scientists who propose cutting-edge—and possibly transformative—approaches to major challenges in biomedical and behavioral research on HIV/AIDS that are relevant to drug abuse. Applications are due November 6, 2013. For more information, see RFA-DA-14-008

New NIDA Grantees Collaborate To Address HIV/AIDS and Drug Use

Late last year, five new research teams began work to address HIV/AIDS and drug use in areas where it is already at epidemic proportions or where it is quickly emerging to become one if efforts are not made to halt or reverse the current momentum. The research projects are the result of NIDA grants designed to stimulate collaborative research among foreign investigators from the same geographic regions to address regional issues on the intersection of HIV/AIDS and drug use in international settings.

NIDA Symposium, Workshop, and IAS-NIDA Fellows Featured at AIDS 2010

Two NIDA-supported meetings featured international drug abuse research during the XVIII International AIDS Conference, which was held July 18–23, in Vienna, Austria. Prevention and Treatment of HIV and AIDS Among Drug-Using Populations: A Global Perspective was chaired by NIDA AIDS Research Program Director Dr. Jacques Normand and featured presentations by NIDA Director Dr. Nora Volkow on the neurobiology of drug use and HIV risk behavior; U.S. Global AIDS Coordinator Dr.

International HIV/AIDS Researchers Eligible for NIDA Avant-Garde Award

The NIDA Avant-Garde Award Program for HIV/AIDS Research is now open to international scientists. This award is designed to support individual scientists of exceptional creativity who propose cutting-edge—and possibly transformative—approaches to major challenges in biomedical and behavioral research on HIV/AIDS that are relevant to drug abuse. The award is intended to support high-impact research that will open new areas of HIV/AIDS research and/or lead to new avenues for treatment and prevention of HIV/AIDS among drug abusers.

NIDA International Program Supports AIDS Treatment as Prevention Workshop Participants

The NIDA International Program supported the participation of scientists from Argentina, Peru, and South Africa at the 2nd International HIV Treatment as Prevention Workshop, which was held April 22–25, 2012, in Vancouver, Canada. The meeting was organized by Julio S.G. Montaner, M.D., University of British Columbia, and featured a keynote address by U.S. Global AIDS Coordinator Ambassador Eric Goosby about the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) perspective on treatment as prevention.

Pages